Evidence map›Paper›PMID 41869979›Full record

ArticleChembiochem : a European journal of chemical biology2026

Detection of an Antagonist Bound to the Neurokinin a Receptor in Styrene-Maleic Acid Lipid Particles by

Samuel Seidl, Aditya Prasad Patra, Chengkang Li, Johanna Becker-Baldus, Stefanie Kaiser, Christoph Reinhart, Clemens Glaubitz

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Samuel SeidlInstitute for Biophysical Chemistry and Center for Biomolecular Magnetic Resonance (BMRZ), Goethe University Frankfurt, Frankfurt am Main, Germany.
Aditya Prasad PatraMax Planck Institute of Biophysics, Frankfurt am Main, Germany.
Chengkang LiInstitute for Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt am Main, Germany.
Johanna Becker-BaldusInstitute for Biophysical Chemistry and Center for Biomolecular Magnetic Resonance (BMRZ), Goethe University Frankfurt, Frankfurt am Main, Germany.ORCID https://orcid.org/0000-0003-1995-7323
Stefanie KaiserInstitute for Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt am Main, Germany.ORCID https://orcid.org/0000-0003-3224-7502
Christoph ReinhartMax Planck Institute of Biophysics, Frankfurt am Main, Germany.ORCID https://orcid.org/0000-0002-3580-1807
Clemens GlaubitzInstitute for Biophysical Chemistry and Center for Biomolecular Magnetic Resonance (BMRZ), Goethe University Frankfurt, Frankfurt am Main, Germany.ORCID https://orcid.org/0000-0002-3554-6586

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

G protein-coupled receptors (GPCRs) are major pharmacological targets, with ≈34% of FDA-approved drugs acting on this protein family. The frequent incorporation of fluorine into small-molecule ligands enables the use of

Indexed as

LipidsMaleatesNeurokinin-1 Receptor AntagonistsStyreneFluorineLigandsMagnetic Resonance SpectroscopyNuclear Magnetic Resonance, BiomolecularFluorineLigandsLipidsMaleatesmaleic acidNeurokinin-1 Receptor AntagonistsStyrene19FGPCRneurokinin A receptorSMALPultra‐fast MAS NMR

Identifiers

PMID41869979
PMCPMC13007275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.